71 – 80 of 134
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Biomarkers for iron metabolism among patients hospitalized with community-acquired pneumonia caused by infection with SARS-CoV-2, bacteria, and influenza
(
- Contribution to journal › Article
-
Mark
Body composition, physical capacity, and immuno-metabolic profile in community-acquired pneumonia caused by COVID-19, influenza, and bacteria : a prospective cohort study
(
- Contribution to journal › Article
-
Mark
COVID-19 Modeling Outcome versus Reality in Sweden
(
- Contribution to journal › Article
-
Mark
Cognitive Behavioral Therapy and Acceptance and Commitment Therapy (CBT-ACT) vs. Standard Care After Critical Illness Due to COVID-19 : Protocol for a Pilot Randomized Controlled Trial
(
- Contribution to journal › Article
-
Mark
Airborne Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Hospitals : Effects of Aerosol-Generating Procedures, HEPA-Filtration Units, Patient Viral Load, and Physical Distance
2022) In Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 75(1). p.89-96(
- Contribution to journal › Article
-
Mark
Factors associated with exclusive breastfeeding at discharge during the COVID-19 pandemic in 17 WHO European Region countries
(
- Contribution to journal › Article
- 2021
-
Mark
Online teaching in physiotherapy education during COVID-19 pandemic in Italy : a retrospective case-control study on students’ satisfaction and performance
(
- Contribution to journal › Article
-
Mark
Association of cardiometabolic risk factors with hospitalisation or death due to COVID-19 : population-based cohort study in Sweden (SCAPIS)
(
- Contribution to journal › Article
-
Mark
Nudging healthcare professionals to improve treatment of COVID-19 : a narrative review
(
- Contribution to journal › Scientific review
-
Mark
Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19
2021)(
- Working paper/Preprint › Preprint in preprint archive